Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine during etomidate induction for valvular heart surgery
ChiCTR2100047536Phase 4Recruiting
- Sponsor
- Center for Anesthesiology, Beijing Anzhen Hospital
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in Cardiac valve disease (VHD) (2 arms), sponsored by Center for Anesthesiology, Beijing Anzhen Hospital. Primary endpoints: Hemodynamics and Inflammatory stress response. Started May 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on ChiCTR2100047536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047536.